Delivery Order SPE2DB22D3501-SPE2DB25FXM09
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $48,118.52 to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract calls for completion by October 10, 2025, with fulfillment from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $12,029.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Promacta 75 mg tablets (30-unit packages). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support program for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $36,088.89, represents a non-set-aside, competitively awarded procurement supporting federal medical supply requirements. The order is scheduled for completion by October 9, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $26,503.50 to AmerisourceBergen Drug Corp for the supply of Promacta 12.5 mg tablets in quantities of 30 units. This firm fixed price contract, awarded on May 22, 2025, with an ultimate completion date of June 13, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract has a ceiling value of $8,026.53 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a $4,417.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Promacta 12.5 mg, with an ultimate completion date of September 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $8,026.53 to AmerisourceBergen Drug Corp for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $8,026.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Promacta 50 mg tablets (30-count units), with an ultimate completion date of October 17, 2025. The award was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across...
- The Defense Logistics Agency awarded a delivery order valued at $8,836.12 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets (30-count packaging) with a completion date of September 4, 2025. The competitive, firm fixed-price award was issued on August 13, 2025, with no set-aside designation. AmerisourceBergen will perform the work at its corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $50,585.52 to AmerisourceBergen Drug Corp for Promacta 50 mg tablets (30-tablet units) with a completion date of September 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXM09Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,029.63 on September 22, 2025, for the supply of Promacta 75 mg tablets (30-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company supplies a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Promacta, an immunosuppressant medication used to treat thrombocytopenia, exemplifies the company's role in fulfilling DLA's pharmaceutical support needs for Defense Health Agency customers and other federal healthcare systems. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements across varying transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/22/25 |